166 related articles for article (PubMed ID: 6230615)
1. [Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens].
Humbert P; Dupond JL; Mallet H; Leconte des Floris R
Presse Med; 1984 Feb; 13(7):439. PubMed ID: 6230615
[No Abstract] [Full Text] [Related]
2. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations.
Spurkland A; Gilhus NE; Rønningen KS; Aarli JA; Vartdal F
Tissue Antigens; 1991 Feb; 37(2):90-3. PubMed ID: 2057938
[TBL] [Abstract][Full Text] [Related]
3. HLA-D in Hashimoto's thyroiditis.
Thomsen M; Ryder LP; Bech K; Bliddal H; Feldt-Rasmussen U; Mølholm J; Kappelgaard E; Nielsen H; Svejgaard A
Tissue Antigens; 1983 Feb; 21(2):173-5. PubMed ID: 6601868
[No Abstract] [Full Text] [Related]
4. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
5. HLA antigens and myasthenia gravis in Japan.
Yoshida T; Tsuchiya M; Ono A; Yoshimatsu H; Satoyoshi E; Tsuji K
J Neurol Sci; 1977 Jun; 32(2):195-201. PubMed ID: 874518
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.
Keesey J; Naiem F; Lindstrom J; Roe D; Herrmann C; Walford R
Arch Neurol; 1982 Feb; 39(2):73-7. PubMed ID: 6977352
[TBL] [Abstract][Full Text] [Related]
7. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.
Savino W; Manganella G; Verley JM; Wolff A; Berrih S; Levasseur P; Binet JP; Dardenne M; Bach JF
J Clin Invest; 1985 Sep; 76(3):1140-6. PubMed ID: 2413072
[TBL] [Abstract][Full Text] [Related]
8. [HLA and myasthenia. Subdivision in 3 categories].
Elchidiac A; Lepage V; Berrih S; Colombani J; Degos L
Pathol Biol (Paris); 1985 Jan; 33(1):50-4. PubMed ID: 3871932
[TBL] [Abstract][Full Text] [Related]
9. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
Scherbaum WA; Schumm F
Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
[No Abstract] [Full Text] [Related]
10. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
11. Correlation of thymic pathology with HLA in myasthenia gravis.
Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis and HLA antigens in American blacks and other races.
Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between Hashimoto's thyroiditis and SD-locus HLA antigens.
Ludwig H; Schernthaner G; Mayr WR; Höfer R
Diabete Metab; 1977 Jun; 3(2):127-30. PubMed ID: 578140
[TBL] [Abstract][Full Text] [Related]
14. Increased frequency of HLA-DR3 and 5 in the syndromes of painless thyroiditis with transient thyrotoxicosis: evidence for an autoimmune aetiology.
Farid NR; Hawe BS; Walfish PG
Clin Endocrinol (Oxf); 1983 Dec; 19(6):699-704. PubMed ID: 6606505
[TBL] [Abstract][Full Text] [Related]
15. Association of goitrous autoimmune thyroiditis with HLA-DR3 in eastern Hungary.
Stenszky V; Balázs C; Kraszits E; Juhasz F; Kozma L; Balázs G; Farid NR
J Immunogenet; 1987; 14(2-3):143-8. PubMed ID: 3500986
[TBL] [Abstract][Full Text] [Related]
16. [Myasthenia and pernicious anemia or Biermer's (author's transl)].
Goulon M; Zittoun J; Tulliez M; Estournet B
Rev Neurol (Paris); 1979 Oct; 135(8-9):605-14. PubMed ID: 394262
[TBL] [Abstract][Full Text] [Related]
17. HLA, anti-DNA, and complement in myasthenia gravis.
Christiansen FT; Houliston JB; Dawkins RL
Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
[TBL] [Abstract][Full Text] [Related]
18. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma receptors and HLA-DR antigens on thymus cells in myasthenia gravis.
Gilhus NE; Matre R
J Neuroimmunol; 1986 Jan; 10(3):271-8. PubMed ID: 2934405
[TBL] [Abstract][Full Text] [Related]
20. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO
Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
